Ticker AKBA – Akebia Ther – sales, description, marketcap – Tickerday.com

AKBA

Akebia Ther

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 342.08M; Volume: 1.06M; AvgVol 3m: 4.77M; Beta: 1.65;

Cost estimate:

P/E: ; EPS: -3.01; EPS growth quarter/prev quarter: -161.00%;

EPS growth this year: 4.50%; EPS growth past 5 years: 21.70%;

EPS ttm: -3.01;

P/S: 1.14; P/B: 1.00; P/Cashflow: 1.32; P/FCF: ;

Sales: 340.16M; Sales growth quarter/prev quarter: -10.60%; Sales growth past 5 years: ;

Profitability:

Gross Margin: 61.70%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -49.80%; ROE – return on equity: -94.70%; LT Debt/Equity: 0.21; Total Debt/Equity: 0.00;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 0.30%; Insider Transactions:-4.45%;

Institutional Ownership: 80.20%; Institutional Transactions: 19.53%;

Data update: 07.10.2020.

Leave a comment

Your email address will not be published. Required fields are marked *